582 CARDIOVASCULAR SAFETY OF DEGARELIX: RESULTS FROM A 12-MONTH, COMPARATIVE, RANDOMIZED, OPEN-LABEL, PARALLEL-GROUP PHASE III TRIAL IN PROSTATE CANCER PATIENTS
Klotz, Laurence, Smith, Matthew, Persson, Bo-Eric, Olesen, Tine Kold, Wilde, ArthurVolume:
183
Language:
english
Journal:
The Journal of Urology
DOI:
10.1016/j.juro.2010.02.841
Date:
April, 2010
File:
PDF, 45 KB
english, 2010